Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, September 27, 2019
GlaxoSmithKline (GSK) has completed a $120 million expansion of its manufacturing site in the Philadelphia suburb of Upper Merion, PA.
read more
Friday, September 27, 2019
Translate Bio has entered into a multi-year strategic manufacturing agreement with AMRI in support of the planned expansion of Translate Bio’s cGMP clinical mRNA manufacturing capabilities.
read more
Thursday, September 26, 2019
GENEWIZ announced the opening of its European headquarters for its genomics business in Leipzig, Germany.
read more
Thursday, September 26, 2019
Torrent is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets to the consumer level.
read more
Wednesday, September 25, 2019
LMC Manna Research announced the opening of two new locations in Ottawa and London Ontario.
read more
Wednesday, September 25, 2019
The FDA has announced a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz used to decrease the amount of acid created by the stomach.
read more
Wednesday, September 25, 2019
Certara® announced the FDA has renewed licenses for Synchrogenix’s electronic Common Technical Document review software, GlobalSubmit REVIEW™ and GlobalSubmit VALIDATE™.
read more
Wednesday, September 25, 2019
Catalent and Minerva Neurosciences have entered into a commercial supply agreement for roluperidone, an investigational compound from Minerva, for symptoms of schizophrenia.
read more
Wednesday, September 25, 2019
Versatope Therapeutics has been awarded a contract with NIAID, a division of the National Institutes of Health (NIH), worth up to $17.9M over five years.
read more
Wednesday, September 25, 2019
Biocon Biologics has acquired R&D capital assets for a 60,000 sq. ft ‘bench to pilot scale’ Biologics research facility at TICEL Bio Park in Chennai from Pfizer Healthcare India.
read more
Tuesday, September 24, 2019
The Cell and Gene Therapy Catapult celebrates the completion of six additional modules at its manufacturing center in Stevenage.
read more
Tuesday, September 24, 2019
Bayer, Brigham and Women's Hospital, and Massachusetts General Hospital announced the launch of a joint lab to research new drug candidates to treat chronic lung diseases.
read more
Monday, September 23, 2019
Immutep will receive a milestone payment from GSK of £4 million related to the first patient being dosed in GSK’s Phase II clinical trial evaluating GSK2831781 for ulcerative colitis.
read more
Monday, September 23, 2019
Hikma Pharmaceuticals has launched a new prefilled syringe capability in the US through its affiliate, Hikma Pharmaceuticals USA Inc.
read more
Monday, September 23, 2019
Varcode has appointed Joseph Battoe as the company’s new president and CEO.
read more